OrthoPediatrics Management
Management criteria checks 3/4
OrthoPediatrics' CEO is David Bailey, appointed in Jun 2020, has a tenure of 4.42 years. total yearly compensation is $2.72M, comprised of 18.4% salary and 81.6% bonuses, including company stock and options. directly owns 0.95% of the company’s shares, worth $5.21M. The average tenure of the management team and the board of directors is 4.1 years and 12.8 years respectively.
Key information
David Bailey
Chief executive officer
US$2.7m
Total compensation
| CEO salary percentage | 18.4% |
| CEO tenure | 4.4yrs |
| CEO ownership | 0.9% |
| Management average tenure | 4.1yrs |
| Board average tenure | 12.8yrs |
Recent management updates
Recent updates
Investors Still Waiting For A Pull Back In OrthoPediatrics Corp. (NASDAQ:KIDS)
Nov 05
The OrthoPediatrics Corp. (NASDAQ:KIDS) Second-Quarter Results Are Out And Analysts Have Published New Forecasts
Aug 09Shareholders Should Be Pleased With OrthoPediatrics Corp.'s (NASDAQ:KIDS) Price
Aug 02OrthoPediatrics Corp. (NASDAQ:KIDS) Just Reported And Analysts Have Been Lifting Their Price Targets
May 09OrthoPediatrics (NASDAQ:KIDS) Has Debt But No Earnings; Should You Worry?
May 07Why Investors Shouldn't Be Surprised By OrthoPediatrics Corp.'s (NASDAQ:KIDS) P/S
Apr 10Why Investors Shouldn't Be Surprised By OrthoPediatrics Corp.'s (NASDAQ:KIDS) P/S
Dec 20Getting In Cheap On OrthoPediatrics Corp. (NASDAQ:KIDS) Might Be Difficult
May 05OrthoPediatrics' (NASDAQ:KIDS) Earnings Aren't As Good As They Appear
Nov 08OrthoPediatrics announces public offering of stock, pre-funded warrants
Aug 10Is OrthoPediatrics (NASDAQ:KIDS) Using Debt In A Risky Way?
Aug 08OrthoPediatrics enters distribution agreement with 3D-Side
Jul 13CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$28m |
| Jun 30 2024 | n/a | n/a | -US$25m |
| Mar 31 2024 | n/a | n/a | -US$22m |
| Dec 31 2023 | US$3m | US$500k | -US$21m |
| Sep 30 2023 | n/a | n/a | -US$22m |
| Jun 30 2023 | n/a | n/a | US$976k |
| Mar 31 2023 | n/a | n/a | US$4m |
| Dec 31 2022 | US$1m | US$415k | US$1m |
| Sep 30 2022 | n/a | n/a | US$9m |
| Jun 30 2022 | n/a | n/a | -US$12m |
| Mar 31 2022 | n/a | n/a | -US$15m |
| Dec 31 2021 | US$906k | US$371k | -US$16m |
| Sep 30 2021 | n/a | n/a | -US$30m |
| Jun 30 2021 | n/a | n/a | -US$33m |
| Mar 31 2021 | n/a | n/a | -US$38m |
| Dec 31 2020 | US$898k | US$371k | -US$33m |
| Sep 30 2020 | n/a | n/a | -US$23m |
| Jun 30 2020 | n/a | n/a | -US$22m |
| Mar 31 2020 | n/a | n/a | -US$15m |
| Dec 31 2019 | US$836k | US$300k | -US$13m |
| Sep 30 2019 | n/a | n/a | -US$11m |
| Jun 30 2019 | n/a | n/a | -US$10m |
| Mar 31 2019 | n/a | n/a | -US$10m |
| Dec 31 2018 | US$590k | US$266k | -US$12m |
| Sep 30 2018 | n/a | n/a | -US$25m |
| Jun 30 2018 | n/a | n/a | -US$26m |
| Mar 31 2018 | n/a | n/a | -US$26m |
| Dec 31 2017 | US$483k | US$258k | -US$24m |
Compensation vs Market: David's total compensation ($USD2.72M) is about average for companies of similar size in the US market ($USD2.22M).
Compensation vs Earnings: David's compensation has increased whilst the company is unprofitable.
CEO
David Bailey (45 yo)
4.4yrs
Tenure
US$2,721,840
Compensation
Mr. David R. Bailey serves as the Chief Executive Officer at OrthoPediatrics Corp. since June 01, 2021. He serves as the President at OrthoPediatrics Corp. since June 3, 2020 and serves as its Director sin...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 15.8yrs | no data | 0.75% $ 4.1m | |
| President | 4.4yrs | US$2.72m | 0.95% $ 5.2m | |
| CFO, Principal Financial & Accounting Officer | 9.8yrs | US$2.04m | 0.62% $ 3.4m | |
| Executive VP of Legal | 15.8yrs | US$1.35m | 0.32% $ 1.8m | |
| President of Scoliosis | no data | US$1.35m | 0.48% $ 2.6m | |
| President of Enabling Technologies | 1.5yrs | US$22.50k | no data | |
| President of Trauma & Deformity Correction | 3.8yrs | US$1.35m | 0.37% $ 2.1m | |
| Senior Vice President of Clinical & Regulatory Affairs | 2.1yrs | no data | no data | |
| Senior Vice President of International Sales | 8.8yrs | no data | no data |
4.1yrs
Average Tenure
54yo
Average Age
Experienced Management: KIDS's management team is considered experienced (4.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 15.8yrs | no data | 0.75% $ 4.1m | |
| President | 3yrs | US$2.72m | 0.95% $ 5.2m | |
| CFO, Principal Financial & Accounting Officer | 9.3yrs | US$2.04m | 0.62% $ 3.4m | |
| Lead Independent Director | 15.8yrs | US$185.00k | 0.086% $ 471.2k | |
| Chair of Surgeon Advisory Board | no data | no data | no data | |
| Director | 13.8yrs | US$180.00k | 0.10% $ 557.0k | |
| Independent Director | 12.8yrs | US$190.00k | 0.053% $ 291.0k | |
| Member of Surgeon Advisory Board | no data | no data | no data | |
| Member of Surgeon Advisory Board | no data | no data | no data | |
| Member of Surgeon Advisory Board | no data | no data | no data | |
| Member of Surgeon Advisory Board | no data | no data | no data | |
| Independent Director | 10.8yrs | US$185.00k | 0.047% $ 257.9k |
12.8yrs
Average Tenure
68yo
Average Age
Experienced Board: KIDS's board of directors are seasoned and experienced ( 12.8 years average tenure).